日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicity.

双功能靶向ADAM17阻断剂CD16(TAB16)介导NK细胞中ADAM17的选择性抑制,并与肿瘤细胞中过表达的ADAM17结合以诱导细胞毒性。

Dixon Kate J, Hullsiek Robert, Wang Sam, Friess Ryan R, Matson Anders W, Soignier Yvette, Lenvik Alexander J, Wu Jianming, Hart Geoffrey T, Felices Martin, Walcheck Bruce

The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activity.

转录因子BCL11B驱动NK细胞的细胞毒性和抗肿瘤活性。

Kumar Akhilesh, Zhang Bin, Baldys Andrew, Fischer Colin, Lenvik Alexander, Felices Martin, Davis Zachary B, Bendzick Laura, Weis Anna J, Bryceson Yenan T, Miller Jeffrey S, Cichocki Frank

Pragmatic, quasi-experimental, pseudo-randomized clinical trial to assess the impact of patient safety monitors on clinical and patient safety outcomes: The Akershus Clinical Trial (ACT) 1

一项务实、准实验、伪随机临床试验,旨在评估患者安全监测对临床和患者安全结果的影响:阿克斯胡斯临床试验 (ACT) 1

Berge, Kristian; Wisløff, Torbjørn; Lippestad, Kristine; Jakobsen, Rune Bruhn; Gjestland, Johanna A; Lenvik, Olav; Husby, Haldor; Lyngbakken, Magnus N; Skråmm, Inge; Røsjø, Helge

TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

TEM8 三特异性杀伤接合剂可结合肿瘤和肿瘤基质,特异性地发挥自然杀伤细胞的抗肿瘤活性

Michael F Kaminski, Laura Bendzick, Rachel Hopps, Marissa Kauffman, Behiye Kodal, Yvette Soignier, Peter Hinderlie, Joshua T Walker, Todd R Lenvik, Melissa A Geller, Jeffrey S Miller, Martin Felices

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation

静息人类自然杀伤细胞中低密度 PD-1 表达具有功能性,且在移植后上调

Zachary Davis, Martin Felices, Todd Lenvik, Sujan Badal, Joshua T Walker, Peter Hinderlie, James L Riley, Daniel A Vallera, Bruce R Blazar, Jeffrey S Miller

Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager

第二代三特异性杀伤接合剂具有强效的细胞溶解活性和特异性的 IL15 递送

Martin Felices, Todd R Lenvik, Behiye Kodal, Alexander J Lenvik, Peter Hinderlie, Laura E Bendzick, Dawn K Schirm, Michael F Kaminski, Ron T McElmurry, Melissa A Geller, Craig E Eckfeldt, Daniel A Vallera, Jeffrey S Miller

Fast track hip fracture care and mortality - an observational study of 2230 patients

快速通道髋部骨折治疗与死亡率——一项纳入2230例患者的观察性研究

Pollmann, Christian Thomas; Røtterud, Jan Harald; Gjertsen, Jan-Erik; Dahl, Fredrik Andreas; Lenvik, Olav; Årøen, Asbjørn

Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37

适应性 NK 细胞抵抗 IL37 驱动的调节性 T 细胞抑制

Dhifaf Sarhan, Keli L Hippen, Amanda Lemire, Skyler Hying, Xianghua Luo, Todd Lenvik, Julie Curtsinger, Zachary Davis, Bin Zhang, Sarah Cooley, Frank Cichocki, Bruce R Blazar, Jeffrey S Miller

Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect

IL-15的持续治疗会通过代谢缺陷耗竭人类NK细胞。

Martin Felices ,Alexander J Lenvik ,Ron McElmurry ,Sami Chu ,Peter Hinderlie ,Laura Bendzick ,Melissa A Geller ,Jakub Tolar ,Bruce R Blazar ,Jeffrey S Miller

IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer

IL-15 超级激动剂 (ALT-803) 增强自然杀伤 (NK) 细胞对抗卵巢癌的功能

M Felices, S Chu, B Kodal, L Bendzick, C Ryan, A J Lenvik, K L M Boylan, H C Wong, A P N Skubitz, J S Miller, M A Geller